Modulation of radiation-induced oral mucositis (mouse) by selective inhibition of β1 integrin

Radiotherapy and Oncology

Volumn 104, Issue 2, 2012, Pages 230-234

  Albert, Maria ^a   Schmidt, Margret ^a   Cordes, Nils ^a   Dörr, Wolfgang ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

1 Integrin; Fractionated irradiation; Oral mucositis

Indexed keywords

AIIB2 ANTIBODY; BETA1 INTEGRIN; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIZATION; IMMUNOFLUORESCENCE; IRRADIATION; MOUSE; NONHUMAN; ORAL MUCOSITIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INDUCED ORAL MUCOSITIS; RADIOSENSITIVITY; RISK ASSESSMENT; TREATMENT RESPONSE;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD29; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG ADMINISTRATION SCHEDULE; FLUORESCENT ANTIBODY TECHNIQUE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C3H; MOUTH MUCOSA; RADIATION INJURIES, EXPERIMENTAL; RANDOM ALLOCATION; REFERENCE VALUES; STOMATITIS; TREATMENT OUTCOME;

EID: 84865771234     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.06.010     Document Type: Article

References (37)

1. L.S. Elting, D.M. Keefe, and S.T. Sonis Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life Cancer 113 2008 2704 2713
2. B.A. Murphy Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy J Support Oncol 5 2007 13 21
3. G. Russo, R. Haddad, and M. Posner Radiation treatment breaks and ulcerative mucositis in head and neck cancer Oncologist 13 2008 886 898
4. N.S. Bese, J. Hendry, and B. Jeremic Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation Int J Radiat Oncol Biol Phys 68 2007 654 661
5. W. Dörr, and J.H. Hendry Consequential late effects in normal tissues Radiother Oncol 61 2001 223 231
6. L.S. Elting, C.D. Cooksley, and M.S. Chambers Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies Int J Radiat Oncol Biol Phys 68 2007 1110 1120
7. D.M. Keefe, M.M. Schubert, and L.S. Elting Updated clinical practice guidelines for the prevention and treatment of mucositis Cancer 109 2007 820 831
8. R.V. Lalla, S.T. Sonis, and D.E. Peterson Management of oral mucositis in patients who have cancer Dent Clin North Am 52 2008 61 77 viii.
9. D.I. Rosenthal, and A. Trotti Strategies for managing radiation-induced mucositis in head and neck cancer Semin Radiat Oncol 19 2009 29 34
10. N. Treister, and S. Sonis Mucositis: biology and management Curr Opin Otolaryngol Head Neck Surg 15 2007 123 129
11. S.T. Sonis Pathobiology of oral mucositis: novel insights and opportunities J Support Oncol 5 2007 3 11
12. W. Dörr Pathogenesis of normal tissue side effects M. Joiner, A. Van der Kogel, Basic clinical radiobiology 4th ed. 2009 Hodder Arnold London [chapter 13]
13. J. Jaal, C. Richter, and W. Dörr Effect of recombinant human keratinocyte growth factor (Δ23-rHuKGF, Palifermin) on inflammatory and immune changes in mouse tongue during fractionated irradiation Int J Radiat Biol 86 2010 860 866
14. R.O. Hynes Integrins: versatility, modulation, and signaling in cell adhesion Cell 69 1992 11 25
15. K.R. Legate, and R. Fassler Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails J Cell Sci 122 2009 187 198
16. N. Cordes, S. Frick, and T.B. Brunner Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1 Oncogene 26 2007 6851 6862
17. N. Cordes, and V. Meineke Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro Strahlenther Onkol 179 2003 337 344
18. N. Cordes, and C.C. Park Beta1 integrin as a molecular therapeutic target Int J Radiat Biol 83 2007 753 760
19. N. Cordes, J. Seidler, R. Durzok, H. Geinitz, and C. Brakebusch Beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury Oncogene 25 2006 1378 1390
20. J.S. Damiano, L.A. Hazlehurst, and W.S. Dalton Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation Leukemia 15 2001 1232 1239
21. D. Estrugo, A. Fischer, and F. Hess Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells PLoS One 2 2007 e269
22. S. Hehlgans, I. Eke, and K. Storch Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells Radiother Oncol 92 2009 362 370
23. P.S. Hodkinson, T. Elliott, and W.S. Wong ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase Cell Death Differ 13 2006 1776 1788
24. J.M. Nam, Y. Onodera, M.J. Bissell, and C.C. Park Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin Cancer Res 70 2010 5238 5248
25. C.C. Park, H.J. Zhang, E.S. Yao, C.J. Park, and M.J. Bissell Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts Cancer Res 68 2008 4398 4405
26. I. Eke, Y. Deuse, and S. Hehlgans β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy J Clin Invest 122 2012 1529 1540
27. R. Al-Jamal, and D.J. Harrison Beta1 integrin in tissue remodelling and repair: from phenomena to concepts Pharmacol Ther 120 2008 81 101
28. W. Dörr, K. Heider, and K. Spekl Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF Int J Radiat Biol 81 2005 557 565
29. A. Fehrmann, and W. Dörr Effect of EGFR-inhibition on the radiation response of oral mucosa: experimental studies in mouse tongue epithelium Int J Radiat Biol 81 2005 437 443
30. A. Gehrisch, and W. Dörr Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa Strahlenther Onkol 183 2007 36 42
31. J. Haagen, H. Krohn, S. Röllig, M. Schmidt, K. Wolfram, and W. Dörr Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies Radiother Oncol 92 2009 472 476
32. W. Dörr Modulation of repopulation processes in oral mucosa: experimental results Int J Radiat Biol 79 2003 531 537
33. W. Dörr Time factors in normal tissue responses to irradiation M. Joiner, A. Van der Kogel, Basic clinical radiobiology 4th ed. 2009 Hodder Arnold London [chapter 11]
34. G. Bungartz, S. Stiller, and M. Bauer Adult murine hematopoiesis can proceed without beta1 and beta7 integrins Blood 108 2006 1857 1864
35. C. Bagutti, C. Hutter, R. Chiquet-Ehrismann, R. Fässler, and F.M. Watt Dermal fibroblast-derived growth factors restore the ability of beta(1) integrin-deficient embryonal stem cells to differentiate into keratinocytes Dev Biol 231 2001 321 333
36. C. Brakebusch, and R. Fässler Beta 1 integrin function in vivo: adhesion, migration and more Cancer Metastasis Rev 24 2005 403 411
37. A. Piwko-Czuchra, H. Koegel, and H. Meyer Beta1 integrin-mediated adhesion signalling is essential for epidermal progenitor cell expansion PLoS One 4 2009 e5488